Form 6-K CHINA LIFE INSURANCE CO For: May 25

Commission File Number 001-31914

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

May 25, 2022

China Life Insurance Company Limited

(Translation of registrant’s name into English)

16 Financial Street

Xicheng District

Beijing 100033, China

Tel: (86-10) 6363-3333

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:

Form 20-F   ☒                Form 40-F   ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

Yes   ☐             No  ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-   ☐

Commission File Number 001-31914

China Life Insurance Company Limited issued an announcement on May 25, 2022, a copy of which is attached as Exhibit 99.1 hereto.

EXHIBIT LIST

Commission File Number 001-31914

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

EXHIBIT 99.1

Commission File Number 001-31914

ANNOUNCEMENT

CHANGE OF MEMBERS OF THE NOMINATION AND REMUNERATION

COMMITTEE

The board of directors (the “Board”) of China Life Insurance Company Limited (the “Company”) announces that due to the adjustment of work arrangements, Mr. Wang Junhui, a Non-executive Director of the Company, has been appointed as a member of the Nomination and Remuneration Committee, and Mr. Yuan Changqing, a Non-executive Director of the Company, has ceased to serve as a member of the Nomination and Remuneration Committee, both with effect from 25 May 2022.

The Nomination and Remuneration Committee after such change comprises Mr. Tang Xin, an Independent Director, Mr. Wang Junhui, a Non-executive Director, and Mr. Lam Chi Kuen, an Independent Director, with Mr. Tang Xin acting as the Chairman of the committee.

Hong Kong, 25 May 2022

As at the date of this announcement, the Board of the Company comprises: